Plasma Therapy Market Report 2025

This Plasma Therapy market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The plasma therapy market size has grown rapidly in recent years. It will grow from $0.49 billion in 2024 to $0.55 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing awareness of the benefits of plasma therapy, government support for plasma therapy, reimbursement coverage for plasma therapy, increasing demand for minimally invasive procedures, rising demand for personalized medicine, growing geriatric population.

The plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $0.88 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing adoption of immunoglobulins, expanding applications, rising demand for rare diseases treatment, customized therapies. Major trends in the forecast period include development of new and improved plasma therapy techniques, biological manufacturing, cell-free plasma therapies, telemedicine integration, research into new applications.

The expected surge in osteoarthritis cases is set to drive growth in the plasma therapy market, particularly highlighting Platelet-rich plasma (PRP) as a safe and effective remedy. PRP, through the injection of concentrated autologous blood growth factors into the affected joint, alleviates symptoms by reducing inflammation and slowing osteoarthritis progression. The Journal of Elsevier's September 2023 report forecasts a substantial global increase in osteoarthritis cases by 2050, spanning various joints like the knee, hand, hip, and other types. This projected surge in osteoarthritis incidences is likely to spur demand for plasma therapy, particularly leveraging the efficacy of PRP.

The anticipated increase in cosmetic and aesthetic procedures is likely to boost the plasma therapy market in the future. These procedures encompass medical and surgical methods designed to enhance or restore a person's appearance by modifying physical traits. Plasma therapy, especially in the form of platelet-rich plasma (PRP), is applied in cosmetic and aesthetic treatments to rejuvenate skin, enhance collagen production, and speed up tissue healing. For example, in August 2023, The Aesthetic Society, a US organization focused on plastic surgery and cosmetic medicine, reported that Americans collectively spent over $11.8 billion on aesthetic procedures, marking a 2% rise from the prior year. Thus, the expansion of cosmetic and aesthetic procedures is contributing to the growth of the plasma therapy market.

Major players in the plasma therapy market are trailblazing with innovative products like the ESG-410, addressing evolving needs and diversifying treatment options. Olympus Corporation, in June 2023, launched the ESG-410, an Electrosurgical Generator optimized for treating NMIBC and benign prostatic hyperplasia. This next-gen generator incorporates advanced design elements like improved capacitors, ensuring superior plasma stability during ignition. With rapid ignition and enhanced plasma stability compared to its predecessor, the ESG-400, this generator introduces varied resection loops, electrodes, and vaporization tools, marking significant progress in treating NMIBC and BPH.

Key contributors in the plasma therapy domain are pioneering novel treatment methods, such as the Thulium Laser Non-Surgical Hair Loss Treatment, to meet evolving demands and expand treatment options. Revealed by researchers at Regeneris Medical Boston in August 2022, this innovation harnesses a specific 1,927 nm fractional thulium laser system coupled with growth factors from High-Density platelet-rich plasma (HDPRP) to stimulate hair regrowth without direct scalp injections. This groundbreaking technique utilizes platelet-rich plasma via Thulium Laser Technology, offering a needle-free, non-invasive approach for treating hair loss.

Major companies operating in the plasma therapy market include Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Plasma therapy involves a treatment method that supplements deficient proteins, aiding individuals in leading healthier and more productive lives. It involves infusing antibodies obtained from donated blood of recovered patients into those undergoing therapy.

The primary forms of plasma therapy encompass pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin (PRF), and leukocyte-rich fibrin (L-PRF). Pure Platelet-Rich Plasma (P-PRP) or leucocyte-poor PRP products are activated preparations lacking leukocytes and possessing a low-density fibrin structure. These varied applications span orthopedics, arthritis, chronic tendinitis, bone repair and regeneration, dermatology, androgenic alopecia, plastic surgery, dental procedures, cardiac muscle injury, among others. These applications find implementation across diverse sectors, including hospitals, clinics, laboratories, and research institutions.

The plasma therapy market research report is one of a series of new reports that provides plasma therapy market statistics, including plasma therapy industry global market size, regional shares, competitors with a plasma therapy market share, detailed plasma therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the plasma therapy industry. This plasma therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

North America was the largest region in the plasma therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The plasma therapy market includes revenues earned by entities by replacing missing or deficient proteins and developing better means of managing the disease. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.